Mapping of monoclonal antibodies specific to P64K: A common antigen of several isolates of Neisseria meningitidis

Canadian Journal of Microbiology

Volumn 47, Issue 2, 2001, Pages 158-164

  Nazabal C ^a   Carmenate, T ^a   Cruz, S ^a   Gonzalez S ^a   Silva, R ^a   Musacchio, A ^a   Delgado, M ^a   Chinea, G ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Epitope mapping; Monoclonal antibodies; Neisseria meningitidis; P64k

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; PROTEIN P64K; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOTINYLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IMMUNOBLOTTING; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CLONING, MOLECULAR; DIHYDROLIPOAMIDE DEHYDROGENASE; EPITOPE MAPPING; EPITOPES; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; PROTEIN STRUCTURE, SECONDARY;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; NEISSERIA MENINGITIDIS;

EID: 0035103058     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjm-47-2-158     Document Type: Article

References (40)

1. Epitope mapping with peptides
2. A lipoamide dehydrogenase from Neisseria meningitidis has a lipoyl domain
3. Monoclonal antibodies against P1, P3 and 31-kDa outer membrane proteins of Neisseria meningitidis B:4:P1.15
4. Epitope mapping of antibodies to acetylcholine receptor α subunits using peptides synthesised on polypropylene pegs
5. Production of monoclonal antibodies: Strategy and tactics
6. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes
7. Production, characterization and control of MenB-Vaccine Folkehelsa: An outer membrane vesicle vaccine against group B meningococcal disease
8. Mechanism of antibody binding to a protein
9. Strategies for epitope analysis using peptide synthesis
10. Chemistry of antibody binding to a protein
11. Purification and immunogenicity of a hybrid recombinant protein including epitopes of P1.15 and PM6 from N. meningitidis
12. A novel cancer vaccine composed of human recombinant epidermal growth factor linked to a carder protein: Report of a pilot clinical trial
13. P64k meningococcal protein as immunological carrier for weak immunological
14. Caracterización estructural y funcional de la proteína recombinante P64k de Neisseria meningitidis
15. The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolated herpes virus hydrophobic proteins or glycoproteins
16. Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis
17. Cloning and expression in Escherichia coli of a high molecular weight outer membrane protein (PM6) from the Neisseria meningitidis strain B:4:P1.15 (Cuban isolate). Evaluation of the immunogenicity and bactericidal activity of antibodies raised against the recombinant protein
18. Expression in Escherichia coli and immunological characterization of a hybrid class 1-64k protein from Neisseria meningitidis
19. Cloning and expression of the porA gene of N. meningitidis strain B:4:P1.15 in E. coli. Preliminary characterization of the recombinant polypeptide
20. Expression in Escherichia coli of the lpd A gene; protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis
21. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
22. Cleavage of structural proteins during assembly of the head of bacteriophage T4
23. Immunoglobulin region of a bactericidal antibody
24. Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis
25. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration
26. Antibody response against the 64 kDa protein from Neisseria meningitidis after systemic meningococcal disease, and after vaccination with two different serogroup B meningococcal vaccines among young adults in Iceland
27. Antigenic determinants in proteins coincide with surface regions accessible to large probes
28. Recombinant meningococcal P64k protein as immunological carrier for synthetic peptides
29. Caveats for the use of surface-adsorbed protein antigen to test the specificity of antibodies
30. Characterisation of the lpdA gene from Neisseria meningitidis by polymerase chain reaction, restriction fragment length polymorphism and sequencing
31. Purification of mouse antibodies and fab fragments
32. Protein-peptide interactions
33. Location of continuous antigenic determinants in the protruding regions of proteins
34. A flaw in the detection of antigenic sites
35. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications
36. WHATIF, a molecular modelling and drug design program
37. Serotyping and subtyping of Neisseria meningitidis isolates by coagglutination, dot-blotting and ELISA
38. Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile